Volver al buscador
FDAFDA · Alimentos y medicamentos·N.º oficial D-1182-2022

Doxycycline (as Calcium) (equivalent to 50mg/5mL), 10 mg/ml, 60 ml suspension bottles, Peppermint, Qty: 1, Wedgewood Village Pharmacy LLC, 405 Heron Dr, Ste 200, Swedesboro, NJ 08085

Publicado el 13 de julio de 2022 · Inicio del retiro: 10 de junio de 2022

Resumen

FDA registra el retiro D-1182-2022 de medicamentos de Clase II, publicado el 13 de julio de 2022 e iniciado el 10 de junio de 2022. Empresa responsable: Wedgewood Village Pharmacy, LLC; Estado: Finalizado; Cantidad reportada: 24 bottles; Lote: Lot#: 000-03852523, Exp Date: 09/01/22; Lot#: 000-03766625, Exp Date:07/10/22; Lot#: 000-03780127, Exp Date: 08/6/22; Lot#: 000-03794760, Exp Date: 08/6/22; Lot#: 000-03892723, Exp Date: 09/1/22; Lot#: 000-03641022, Exp Date: 06/17/22; Lot#: 000-03693714, Exp Date: 06/28/22; Lot#: 000-03770510, Exp Date: 08/6/22; Lot#: 000-03852462, Exp Date: 09/1/22; Lot#: 000-03840601, Exp Date: 09/1/22; Lot#: 000-03706934, Exp Date: 06/28/22; Lot#: 000-03850609, Exp Date: 09/1/22; Lot#: 000-03650269, Exp Date: 06/17/22; Lot#: 000-03870004, Exp Date: 09/1/22; Lot#: 000-03693748, Exp Date: 06/28/22; Lot#: 000-03904403, Exp Date: 09/1/22; Lot#: 000-03799564, Exp Date: 08/06/22; Lot#: 000-03723022, Exp Date: 06/28/22; Lot#: 000-03872892, Exp Date: 09/01/22; Lot#: 000-03885204, Exp Date: 09/01/22; Lot#: 000-03848586, Exp Date: 09/01/22; Lot#: 000-03903599, Exp Date: 09/01/22; Lot#: 000-03812001, Exp Date: 08/06/22. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.

Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.

Qué peligro representa

Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection

Qué hacer

Voluntary: Firm initiated

Recibe un correo cuando FDA publique un retiro como este

Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.

Detalles del retiro

Fabricante
Wedgewood Village Pharmacy, LLC
Distribuidor
Products were distributed nationwide in the USA.
Lote
Lot#: 000-03852523, Exp Date: 09/01/22; Lot#: 000-03766625, Exp Date:07/10/22; Lot#: 000-03780127, Exp Date: 08/6/22; Lot#: 000-03794760, Exp Date: 08/6/22; Lot#: 000-03892723, Exp Date: 09/1/22; Lot#: 000-03641022, Exp Date: 06/17/22; Lot#: 000-03693714, Exp Date: 06/28/22; Lot#: 000-03770510, Exp Date: 08/6/22; Lot#: 000-03852462, Exp Date: 09/1/22; Lot#: 000-03840601, Exp Date: 09/1/22; Lot#: 000-03706934, Exp Date: 06/28/22; Lot#: 000-03850609, Exp Date: 09/1/22; Lot#: 000-03650269, Exp Date: 06/17/22; Lot#: 000-03870004, Exp Date: 09/1/22; Lot#: 000-03693748, Exp Date: 06/28/22; Lot#: 000-03904403, Exp Date: 09/1/22; Lot#: 000-03799564, Exp Date: 08/06/22; Lot#: 000-03723022, Exp Date: 06/28/22; Lot#: 000-03872892, Exp Date: 09/01/22; Lot#: 000-03885204, Exp Date: 09/01/22; Lot#: 000-03848586, Exp Date: 09/01/22; Lot#: 000-03903599, Exp Date: 09/01/22; Lot#: 000-03812001, Exp Date: 08/06/22;
Clasificación de riesgo
Class II
Área (FDA)
drug
País
United States

Retiros relacionados

Preguntas sobre este retiro

¿Doxycycline (as Calcium) (equivalent to 50mg/5mL), 10 mg/ml, 60 ml suspension bottles, Peppermint, Qty: 1, Wedgewood Village Pharmacy LLC, 405 Heron Dr, Ste 200, Swedesboro, NJ 08085 fue retirado del mercado?

Sí. FDA publicó el retiro D-1182-2022 el 13 de julio de 2022. Peligro reportado: Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection

¿Qué debo hacer si tengo este producto?

Voluntary: Firm initiated